| MAPT-Mutant Neurons | |
|---|---|
| Mutation Type | Frontotemporal Dementia / Corticobasal Degeneration |
| Gene Affected | MAPT (Microtubule-Associated Protein Tau) |
| Common Mutations | P301L, P301S, R406W, V337M, G272V, K369I |
| Inheritance | Autosomal Dominant |
| Disease | Frontotemporal Dementia, Corticobasal Degeneration |
Mapt Mutant Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
MAPT-mutant neurons carry pathogenic mutations in the microtubule-associated protein tau (MAPT) gene, which cause hereditary frontotemporal dementia (FTD) and corticobasal degeneration (CBD). These mutations directly lead to tau protein dysfunction, including impaired microtubule binding, altered splicing, and enhanced aggregation. MAPT mutations account for approximately 5-10% of familial FTD cases.
Tau is a microtubule-associated protein primarily expressed in neurons that:
Mutations affect tau through several mechanisms:
| Mechanism | Example Mutations | Effect |
|---|---|---|
| Reduced binding | P301L, P301S, G272V | Less microtubule stabilization |
| Splicing changes | 10+16, 10+3 | Increased 4R-tau ratio |
| Aggregation | P301L, P406W | Enhanced fibril formation |
| Phosphorylation | Multiple | Hyperphosphorylation |
MAPT mutations lead to:
MAPT-mutant neurons show:
| Feature | MAPT-Mutant | Control |
|---|---|---|
| Tau aggregation | Elevated | None |
| Phosphorylation | Hyperphosphorylated | Baseline |
| Microtubule stability | Reduced | Normal |
| Axonal transport | Impaired | Functional |
| 4R/3R ratio | Often altered | Balanced |
MAPT mutations preferentially affect:
Mapt Mutant Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mapt Mutant Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.